C Code

ALL CODES   A CODE   B CODE   C CODE   CPT CODE   J CODE   NOC CODE   P CODE   Q CODE   S CODE  COST

ADZYNMA – C9167

ADZYNMA is aligned to the C Code: C9167. ADZYNMA is a Hematology medication produced by Takeda Pharmaceuticals America, Inc. and administered via the Intravenous route of administration.

Read More »

OMVOH – C9168

OMVOH is aligned to the C Code: C9168. OMVOH is a Gastrointestinal product produced by Eli Lilly And Company and administered via the Subcutaneous route of administration.

Read More »

COSENTYX – C9166

COSENTYX is aligned to the C Code: C9166. COSENTYX is an Anti-TNF medication produced by Novartis Pharmaceuticals Corporation and administered via the Intravenous route of administration.

Read More »

DAXXIFY – C9160

DAXXIFY is a Botulinum Toxin drug manufactured by Revance Therapeutics, Inc. and administered via the Intramuscular route of administration. The C Code: C9160 is aligned to the drug DAXXIFY.

Read More »

BALFAXAR – C9159

BALFAXAR is an Anticoagulant drug manufactured by Octapharma USA Inc and administered via the Intravenous route of administration. The C Code: C9159 is aligned to the drug BALFAXAR.

Read More »

EYLEA HD – C9161

EYLEA HD is an Opthalmic drug manufactured by Regeneron Pharmaceuticals, Inc and administered via the Intraocular route of administration. The C Code: C9161 is aligned to the drug EYLEA HD.

Read More »

IZERVAY – C9162

IZERVAY is an Opthalmic drug manufactured by IVERIC bio, Inc. and administered via the Intraocular route of administration. The C Code: C9162 is aligned to the drug IZERVAY.

Read More »

TALVEY – C9163

TALVEY is an Oncology drug manufactured by Janssen Biotech and administered via the Subcutaneous route of administration. The C Code: C9163 is aligned to the drug TALVEY.

Read More »

YCANTH – C9164

YCANTH is a Topical keratolytics drug manufactured by Verrica Pharmaceuticals and administered via the Topical application route of administration. The C Code: C9164 is aligned to the drug YCANTH.

Read More »

ELREXFIO – C9165

ELREXFIO is an Oncology drug manufactured by Pfizer and administered via the Subcutaneous route of administration. The C Code: C9165 is aligned to the drug ELREXFIO.

Read More »